EGFR and cancer: The EGFR/Akt signaling cascade has been identified as a crucial oncogenic regulator in various cancers, including non-small cell lung cancer(NSCLC) (Chandrasekaran et al., 2017) and prostate cancer (Gan et al., 2010).